Bank of Montreal
PBE icon

Bank of Montreal’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bank of Montreal’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49K Sell
619
-111
-15% -$8.97K ﹤0.01% 3299
2025
Q4 		$60K Hold
730
– – ﹤0.01% 3161
2025
Q3 		$51K Hold
730
– – ﹤0.01% 3117
2025
Q2 		$46.8K Hold
730
– – ﹤0.01% 3151
2025
Q1 		$46.3K Hold
730
– – ﹤0.01% 3083
2024
Q4 		$48.6K Sell
730
-2,735
-79% -$189K ﹤0.01% 3116
2024
Q3 		$242K Hold
3,465
– – ﹤0.01% 2912
2024
Q2 		$230K Hold
3,465
– – ﹤0.01% 2908
2024
Q1 		$227K Hold
3,465
– – ﹤0.01% 2967
2023
Q4 		$231K Hold
3,465
– – ﹤0.01% 3030
2023
Q3 		$213K Hold
3,465
– – ﹤0.01% 3031
2023
Q2 		$220K Buy
3,465
+2,735
+375% +$171K ﹤0.01% 3159
2023
Q1 		$47.7K Hold
730
– – ﹤0.01% 3379
2022
Q4 		$48.6K Sell
730
-95
-12% -$6.03K ﹤0.01% 3550
2022
Q3 		$54 Hold
825
– – ﹤0.01% 3620
2022
Q2 		$49 Sell
825
-57
-6% -$3.28K ﹤0.01% 3633
2022
Q1 		$55K Hold
882
– – ﹤0.01% 3775
2021
Q4 		$64K Buy
882
+465
+112% +$33.7K ﹤0.01% 3200
2021
Q3 		$32K Hold
417
– – ﹤0.01% 3604
2021
Q2 		$33K Buy
+417
New +$31K ﹤0.01% 3467
2016
Q4 		– Sell
-200
Closed -$8K – 4152
2016
Q3 		$8K Hold
200
– – ﹤0.01% 3609
2016
Q2 		$7K Hold
200
– – ﹤0.01% 3666
2016
Q1 		$8K Hold
200
– – ﹤0.01% 3680
2015
Q4 		$10K Buy
+200
New +$9.88K ﹤0.01% 3621
2014
Q3 		– Sell
-1,000
Closed -$44K – 4307
2014
Q2 		$44K Hold
1,000
– – ﹤0.01% 3252
2014
Q1 		$42K Hold
1,000
– – ﹤0.01% 3200
2013
Q4 		$37K Hold
1,000
– – ﹤0.01% 2990
2013
Q3 		$35K Buy
+1,000
New +$33.1K ﹤0.01% 2988

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.75B AUM 28.61% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Bank of Montreal's PBE Position: Q1 2026 in Review

Bank of Montreal reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 15% in Q1 2026, selling an estimated $8.97K and leaving 619 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #3299.

Bank of Montreal first reported a position in PBE in Q3 2013 and has held it in 28 quarters since. The position peaked at $242K in Q3 2024. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.

  • Bank of Montreal held 619 shares of Invesco Biotechnology & Genome ETF worth $49K as of Q1 2026.
  • Bank of Montreal sold 111 Invesco Biotechnology & Genome ETF shares in Q1 2026, an estimated $8.97K.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #3299 holding.
  • Bank of Montreal first reported a position in Invesco Biotechnology & Genome ETF in Q3 2013 and has held it in 28 quarters since.
  • Bank of Montreal's Invesco Biotechnology & Genome ETF position peaked at $242K in Q3 2024.
  • 100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.